Abstracts
Showing 817 abstracts.
Efavirenz Pharmacokinetics during the 3rd Trimester of Pregnancy and Postpartum
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1026S
Interim Results from IMPAACT P1066: Raltegravir (RAL) Oral Chewable Tablet (CT) Formulation in Children 2-5 Years
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1066
Increased Microbial Translocation in Pediatric HIV-infection is Associated with Viral Load, Independent of CD4 Count
Conference
18th Conference on Retroviruses & Opportunistic Infections
Stability of Resting CD4+ T Cell HIV-1 Reservoirs following Immunization With Recombinant Poxvirus HIV-1 Vaccines
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1059
Association of HIV Diversity and Survival in HIV-infected Ugandan Infants
Conference
18th Conference on Retroviruses & Opportunistic Infections
Initiation of Antiretroviral Treatment in Women after Delivery Can Induce Multi-class Drug Resistance in Breastfeeding HIV-infected Infants: Findings from the PEPI-Malawi trial
Conference
18th Conference on Retroviruses & Opportunistic Infections
Women Identified as Recently Infected at the Time of Delivery Using a Multi-assay Algorithm for HIV Incidence had a Higher Rate of In Utero HIV Transmission: Findings from the PEPI-Malawi Trial
Conference
18th Conference on Retroviruses & Opportunistic Infections
Comparison of Abbott HIV-1 Total Nucleic Acid Qualitative Assay to Roche HIV-1 DNA Assay Using Dried Blood Spots
Conference
18th Conference on Retroviruses & Opportunistic Infections
Nevirapine (NVP)- vs. Lopinavir-Ritonavir (LPV/r)-Based Antiretroviral Therapy (ART) among HIV-Infected Infants in Resource-Limited Settings: The IMPAACT P1060 Trial
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1060
Phase III Randomized Trial of the Safety and Efficacy of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1043/HPTN 040